Out Fox The $treet

Joby Aviation is deeply undervalued at $7, despite strong progress toward eVTOL certification and air taxi launch. The potential $750M ATM capital raise, linked to the $500M Resonant Sciences acquisition, pressures the stock but adds a $100M+ revenue defense unit. JOBY is on track for a $2B revenue target by 2030, with near-term catalysts including eIPP services in Dallas-Fort Worth and Dubai. Certification delays and ongoing capital raises remain key risks, but current weakness offers a compelling buying opportunity. Joby Aviation, Inc.  ( JOBY ) appears to have a bright future, but the company can't stop making untimely capital raises. The stock trades at multi-year lows despite the progress towards eVTOL certification and air taxi  launch. My  investment thesis  remains ultra Bullish on the stock trading around $7, but Joby Aviation is unlikely to rally as long as the company constantly raises capital regardless of the stock price. Read the full article on Seekin...

  Firefly Aerospace Inc. trading at a discount to peers amid strong quarterly results and robust backlog growth. The Q2 backlog surged to a record $1.5 billion, supported by moon landing missions and Lockheed Martin launches, supporting a strong long-term growth trajectory. FLY's revenue guidance for 2026 remains $420–$450 million, with order timing causing quarterly volatility. The stock only trades at 4x 2028 sales targets, while rocket launch companies trade at multiples of this price. Firefly Aerospace Inc. ( FLY ) was an amazing gift on the dip back to support around $20. The space infrastructure company continues to pull large orders as Firefly expands manufacturing capabilities to ride the space race. My  investment thesis  remains ultra Bullish on FLY stock, which is trading at a discount to other rocket launch and space companies. Read the full article on Seeking Alpha. Disclosure: No position. mentioned. Please review the disclaimer page for more details

Update - Aug. 19, 2026 MODERNA, MERCK  MRNA  CANCER VACCINE SUCCEEDS IN PHASE 3, stock up nearly 150% to $153 mid-day trading. The stock is now up nearly 500% from where our research highlighted the potential benefits of a cancer vaccine.  - MRNA  and  MRK  say their personalized mRNA cancer vaccine, intismeran, combined with Keytruda slowed melanoma recurrence and spread in a late-stage trial. -The study was stopped at its first interim analysis after positive results, though detailed efficacy data have not yet been released.   Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Oct. 31, 2025 Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on mRNA Covid vaccines boosting cancer surv...

  Aurora Innovation faces intensifying competition amid slow scaling, with only 200 autonomous trucks targeted by end-2026. AUR's transition from TaaS to DaaS will boost margins but reduce per-truck revenue in 2027. The $14B market cap appears stretched given projected revenue ramp, ongoing dilution, and high cash burn through at least 2028. I remain neutral, seeing the stock range-bound ($4–$8) due to premium valuation, execution risks, and lack of compelling upside catalysts. In the blink of an eye, Aurora Innovation, Inc. ( AUR ) is already inundated with competition. The proclaimed autonomous trucking leader has been slow to launch services and the sector is quickly catching up. My  investment thesis  remains Neutral on the stock, though $6 could provide support for a bounce. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details. 

  Rocket Lab Corporation boasts robust business momentum but trades at an aggressively high valuation, unsupported by Neutron rocket testing delays. The company announced a big $2.36B backlog with $1B+ in new contracts, highlighting the strong business climate in the space sector. RKLB’s planned $8B Iridium acquisition requires heavy equity issuance, adding dilution risk while integration and growth benefits remain years away. With a 50x sales multiple, 40% gross margins, and slowing pro forma growth, RKLB’s stock price remains disconnected from realistic growth and profitability timelines. Rocket Lab Corporation  ( RKLB ) remains a great example of a strong business mismatched with an aggressively priced equity valuation. Most investors view a stock trading in lockstep with revenue or earnings growth, but the current  valuation of Rocket Lab requires years of execution to warrant this price. My  investment thesis  remains bearish on the stock after the company ...

Update - Aug. 10, 2026 RUM Group with a huge start as an AI cloud company. The company has the assets for $3B+ of ARR next year. The stock is a gift here nearly flat in AHs after reporting the following numbers with Q2 results.  ~ Record Revenue of $40.4 Million up 61% YoY ~ ~   Closed Acquisition of Northern Data, Adding Approximately 250 MW of Unmonetized 2027 Targeted Capacity Representing a $3B+ ARR Opportunity ~ ~ Initiating Formal Guidance Beginning with Third Quarter 2026 Revenue Outlook of $87 Million to $93 Million ~ Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on May30 Rumble Inc. is pivoting from video streaming to AI cloud services with the imminent Northern Data acquisition, targeting major AI compute opportunities. Post-merger, RUM expects a sales baseline of ~$425 million, driven by Tether commitments and GPU rental expansion, posit...

  SoFi Technologies delivered 41% YoY revenue growth, and record loan originations. The flywheel effect and SoFi Plus adoption drove robust member and product growth, providing a recurring revenue stream for the future. The fintech guided conservatively due to adopting the view of up to 2 Fed rate hikes this year versus original expectations of rate cuts. The stock is cheap trading at just 13x 2026 adjusted EBITDA targets while consensus estimates project strong growth into 2028, including 52% EBITDA growth this year. SoFi Technologies, Inc.  ( SOFI ) continues reporting amazing results, yet the stock is stuck 50% below the all-time highs. The fintech is firing on all cylinders regardless of guidance for more market-related headwinds in the  2H. My  investment thesis  remains ultra Bullish on the stock as the market is not accurately valuing SoFi based on the growth dynamics. Read the full article on Seeking Alpha.  Disclosure: Long SoFi. Please review the...